Conference Schedule
60th Annual Conference of Indian Society of Haematology and Blood Transfusion
PRE-CONFERENCECME – 7th NOVEMBER 2019
TIME HALL C1
( CME)
HALL C2
(CME)
HALL D
(LAB TECHNICIAN-CME)
HALL E
( NURSING CME)
8.00 Onwards REGISTRATION  

 

09.30 – 11.00 Red Cell Disorders Thrombosis & Hemostasis
09.30 – 09.50 Pathophysiology of IDA: Newer Concepts
Dr. Jyoti Bajaj, Ahmedabad
APLA: Diagnosis & Risk Assessment:
Dr. S Venketesh, Pune
09.50 – 10.10 Best Practices on iron replacement therapy:
Dr. Subhash Varma, Chandigarh
Platelet activation in evaluation of thrombotic risk in clinical settings
Dr. M Kannan, Chennai
10.10 – 10.30 Immune Haemolytic Anemia: Diagnosis and Management
Dr. Nitin Gupta, Delhi
Therapeutic INR not achieved: What Next?
Dr. Sudhir Kumar Attri, Rohtak
10.30 – 10.50 MDS: Pitfalls in Diagnosis
Dr. Neelam Varma, Chandigarh
Lab monitoring of patients on DOACs:
Dr. JM Khunger, Delhi
10.50 – 11.00 Discussion
11.00 – 11.30 BREAK
11.30 – 13.00 Lymphoma Consultative Hematology
11.30 – 11.50 Classification of NHL: What is New?
Dr. Elaine Jaffe, USA
Disseminated Intravascular Coagulation (DIC): Diagnostic Issues:
Dr. U Srinivas, Hyderabad
11.50 – 12.10 Grey zone lymphoma: Pathobiology:
Dr. S. Gujral, Mumbai
Management Anemia in Elderly:
Dr. Jasjeet Singh, Chandigarh
12.10 – 12.30 Management of PTCL
Dr. Jane Winter, USA
Anemia of Chronic Disease
(ACD): Diagnostic Approach
Dr. Gurmeet Singh, Bhilai
12.30 – 12.50 Post-transplant Lympho-proliferative disease (PTLD):
Dr. Rajat Kumar, Canada
Hemophagocytic Lymphohistiocytosis (HLH) in Adults:
Dr. Sanjeev Sharma, Delhi
12.50 – 13.00 Discussion
13.00 – 14.00 LUNCH
14.00 – 15.30 Stem cell transplant Paediatric Hemtatology
14.00 – 14.20 Donor selection for allogeneic Transplant
Dr. Uma Kanga, Delhi
Approach to a child with Bleeding disorder
Dr. Rajib De, Kolkata
14.20 – 14.40 Investigating chimerism in my BMT practice Transient Abnormal Myelopoiesis (TAM)
Dr. Anita Chopra, Delhi
14.40 – 15.00 Infection Prophylaxis in BMT Recipients: Best Practices
Dr. Nandita Khera, USA
Neonatal Thrombosis: Issues in Management:
Dr. Sunil Gupta, Bengaluru
15.00 – 15.20 CART cells: Have they met our expectations?
Dr. Navneet Majhail, USA
Approach to Inherited BMFS:
Dr. Avinash Singh, Patna
15.20 – 15.30 Discussion Discussion
15.30 – 16.00
16.00 – 17.30 Lymphoma/Leukemia Diagnostic Hematology
Chairs: Dr. D.K.Mishra, Kolkata
16.00 – 16.20 CMML: Risk Stratification and Management
Dr. Dharma Choudhary, Delhi
Role of cytogenetics in Myeloid malignancies
Dr. Mayur Parihar, Kolkata
16.20 – 16.40 Acute Promyelocytic Leukemia (APL): How to manage in 2019?
Dr. Auro Vishwabandya, Canada
Role of NGS in Hematological Malignancies:
Dr. Neeraj Arora, Kolkata
16.40 – 17.00 Secondary Leukemias: Pathophysiology & Molecular Biology
Dr. Sayed Hassan, Mumbai
Bone marrow fibrosis and necrosis: How to Approach?
Dr. Narendra Tejwani, Delhi
17.00 – 17.20 Management of Primary CNS Lymphoma
Dr. Anirudh Dayama, Delhi
Role of Free Light Chain Assay in plasma cell dyscrasias
Dr. Ritu Gupta, Delhi
17.20 – 17.30 Discussion
CONFERENCE DAY 1 – 8thNOVEMBER 2019
TIME HALL A HALL B HALL C HALL D
7.00 Onwards REGISTRATION
08.00 – 08.45 Meet the Professors ( 4 Parallel Halls)

  • Acute Lymphoblastic Leukemia(Dr. Robin Foa, Italy; Dr. David Marks, UK; Dr. Mammen Chandy, Kolkata)
  • Transplant- GVHD ( Dr. Navneet Majhail, USA; Dr. Minoo Battiwalla, USA; Dr. Vikram Mathews, Vellore)
  • Plasma cell Disorders (Dr. Shaji Kumar, USA; Dr. Pankaj Malhotra, Chandigarh )
  • Bone marrow failure ( Dr. Rajat Kumar, Canada; Dr. Biju George, Vellore)
08.30 – 09.00 BUMPER QUIZ [HALL – A]
Faculty In charge: Dr. Mukul Aggrawal & Dr. Jasmita Das
09.00 – 10.30 PLENARY SESSION ( HALL: A) –ISHBT- ASH JOINT SYMPOSIUM( Topic: Lymphoma)
Chairs: Dr. Elaine Jaffe, USA; Dr. Alok Srivastava, Vellore; Dr. Renu Saxena, Delhi
Diagnostic Approach to Large cell Lymphomas: Dr. Elaine Jaffe, USA
Management of DLBCL: Beyond R-CHOP: Dr. Jane Winter, USA
Updates in Follicular Lymphoma management; Dr. Mammen Chandy, Kolkata
10.30 – 11.00 JB CHATTERGEA ORATION
11.00 – 11.30 COFFEE BREAK
11.30 – 12.45 AML1 Plasma Cell disorders SCT1
[Chairs: Dr. Navneet Majhail, USA; ]
Hemophilia
11.30 – 11.50 Using molecular assessment for prognosis in AML:
Dr. Swati Pai, Bengaluru
Diagnosis and risk stratification of newly diagnosed Myeloma
Dr. Jyoti Kotwal, Delhi
Biomarkers in Acute GVHD: Do they influence Practice?
Dr. Vikram Mathews, Vellore
Factor Replacement therapy in Hemophilia: What is New?
Dr. Shashi Apte, Pune
11.50 – 12.10 How do I incorporate novel drugs in my AML management?
Dr. Ajay Sharma, Delhi
Smoldering Myeloma: To treat or not to treat?
Dr. Suman Parmanik, Delhi
Recent advances in acute GVHD management
Dr. Nandita Khera, USA
Inhibitors in Hemophilia: Risk factors and Diagnosis
Dr. Shrimati Shetty, Mumbai
12.10 – 12.30 Managing the Elderly AML Patient
Dr. Rajat Kumar, Canada
Management of Relapsed Myeloma: Making the right treatment choice
Dr. Shaji Kumar, USA
Donor Lymphocyte Infusions: using an old weapon with new Insights
Dr. Sharat Damodar, Bengaluru
New Approaches in management of Inhibitors in Hemophilia
Dr. Farah Jijina, Mumbai
12.30 – 12.45 Discussion
12.45 – 13.45 Sponsored Symposium
(GRIFOLS)
Sponsored Symposium
(EMCURE)
Sponsored Symposium
(PFIZER)
Sponsored Symposium
13.30 – 14.30 LUNCH
14.30 – 15.30 ORAL ABSTRACT SESSIONS
(6 papers)
ORAL ABSTRACT SESSIONS
(6 papers)
ORAL ABSTRACT
SESSIONS
(6 papers)
ORAL ABSTRACT SESSIONS
(6 papers)
15.30 – 16.45 MPN1 SCT2 Hemoglobinopathy1 Thrombosis
15.30 – 15.50 Diagnosing MPNs-Tips and tricks of the trade for hematopathologist
Dr. Tejinder Singh, Delhi
Managing refractory chronic GVHD-Bane of every transplant physician:
Dr. Navneet Majhail, USA
Diagnosis and management of Iron Overload in thalassemia
Dr. Maitreyee Bhattacharya, Kolkata
Hypercoagulable state: Whom to investigate and How?
Dr. Jasmina Ahluwalia, Chandigarh
15.50 – 16.10 Management of primary myelofibrosis-State of the art;
Dr. Abhay Bhave, Mumbai
Haplo identical donor stem cell transplant in India: Promises and Challenges
Dr. Alok Srivastava, Vellore
MRI for iron Overload assessment: What haematologists need to know?
Dr. JM Walker, UK
Choosing DOACs: Right anticoagulation for right patient
Dr. Tarun Varma, Mumbai
16.10 – 16.30 Managing “problem” cases of PV and ET:
Dr. MB Agarwal, Mumbai
Post-transplant survivorship & quality of life:
Dr. Dr. Minoo Battiwalla, USA
Alternative donor transplant for Thalassemia: For whom and How?
Dr. Rajinder Bajwa, USA
HITT: Pathophysiology and Diagnosis
Dr. Pankhi Dutta, UAE
16.30 – 16.45 Discussion Discussion
16.45 – 17.15 TEA BREAK WITH POSTER WALK
17.15 – 18.00 DEBATE (Clinical)
[Chairs: Dr. Hari Parmeswaran, USA; ]
DEBATE ( Laboratory)
[Chair: Dr. Renu Saxena, Delhi; ]
Learning Through interesting Case/s (Laboratory) Learning Through interesting Case/s (Clinical)
MRD should be the goal of therapy in Myeloma Automated Hemogram is making peripheral smear examination redundant Hemolytic Anemia (20min):
Dr. Bhushan Asthana, Rajouri
Infections in Hematology ( 20 min):
Dr. Sanjeet Dadwal, USA
17.15 – 17.30
17.30 – 17.45
Yes: Dr. Pankaj Malhotra, Chandigarh
No: Dr. Shaji Kumar, USA
Yes: Dr. Sukesh Nair, Vellore
No: Dr. Debdutta Basu, Puduchery
Unusual Cytopenias ( 20 min):
Dr. Man Updesh Sachdeva, Chandigarh
Microangiopathic haemolytic anemia (20 min):
Dr. Rahul Bhargava, Delhi
17.45 – 18.00 Discusssion Discussion
18.00 – 18.30 BREAK
18.30 – 19.30 INAUGURATION CEREMONY FOLLOWED BY CULTURAL PROGRAM
19.30 Onwards DINNER
CONFERENCE DAY 2 – 9th NOVEMBER 2019
TIME HALL A HALL B HALL C HALL D
7.00 Onwards REGISTRATION
07.30 – 08.15 Meet the Professors ( 4 Parallel Halls)

  • Lymphoma ( laboratory): (Dr. Elaine Jaffe, USA; Dr. Renu Saxena, Delhi)
  • Lymphoma ( Clinical): Dr. Jane Winter, USA; Dr. Tapan Saikia, Mumbai)
  • ITP: ( Dr. David Kuter, USA; Dr. AK Tripathi, Lucknow)
  • Transplant- Donor Selection ( Dr. Nandita Khera, USA; Dr. Hari Parmeswaran, USA; Dr. Alok Srivastava, Vellore)
08.00 – 08.30 BUMPER QUIZ [HALL – A]
Faculty In charge: Dr. Prashant Sharma & Dr. Gaurav Prakash
08.30 – 10.00 PLENARY SESSION ( HALL: A) –ISHBT- EHA JOINT SYMPOSIUM( Topic: Acute Lymphoblastic Leukemia)
Chairs: Dr. Robin Foa, Italy; Dr. R.K.Jena, Cuttack; Dr. H.P.Pati, Delhi
Management of Ph- positive ALL: Dr. Robin Foa, Italy
Allogeneic Transplant for ALL: Dr. David Marks, UK
MRD testing in ALL- Technical aspects and clinical interpretation: Dr. D.K. Mishra, Kolkata
10.00 – 10.30 MANORAMA SAPRE ORATION
10.30 – 11.00 COFFEE BREAK
11.00 – 12.15 MDS1 Lymphoma2 Plama cell disorders 2 Pediatric Hematology
11.00 – 11.20 Incorporating mutation testing in MDS management
Dr. Nikhil Patkar, Mumbai
Distinguishing Hodgkin lymphoma from mimickers and copycats
Dr. Tathagata Chatterjee, Delhi
Pattern of Myeloma Relapse: When to Treat?
Dr. Prantar Chakrabarti, Kolkata
Fanconi Anemia: Disease Biology and Molecular Diagnosis
Dr. Shaji RV, Vellore
11.20 – 11.40 Management of Low-Risk MDS
Dr. Pravas Mishra, Delhi
First line therapy of Hodgkin lymphoma in the new millennium
Dr. Dinesh Bhurani, Delhi
Lab Approach to Amyloidosis:
Dr. Anand C Annan, Delhi
Managing SCD: Beyond Hydroxyurea
Dr. R. K. Jena, Cuttack
11.40 – 12.00 How I choose transplant for my MDS patients
Dr. Naveen Khattry, Mumbai
Relapsed and Refractory Hodgkin lymphoma management
Dr. Hari Menon, Bengaluru
Where do I place CART cell in Myeloma Treatment:
Dr. Hari Parmeswaran, USA
How I incorporate stem cell transplant in SCD management
Dr. Auro Vishwabandya, Canada
12.00 – 12.15 Discussion
12.15 – 13.15 Sponsored Symposium
(NOVARTIS)
Sponsored Symposium
( TAKEDA)
Sponsored Symposium
(BHARAT SERUM)
Sponsored Symposium
(NOVO-NORDISK)
Session by
Pfizer (Anti Infective)
13.00 – 14.00 LUNCH
14.00 – 15.00 ORAL ABSTRACT SESSIONS
(6 papers)
ORAL ABSTRACT SESSIONS
(6 papers)
ORAL ABSTRACT
SESSIONS
(6 papers)
ORAL ABSTRACT SESSIONS
(6 papers)
15.00 – 16.15 CML1 Bone Marrow failure Lymphoma 2 Supportive Care
Chairs:[Dr. Sanjeet Dadwal]
15.00 – 15.20 Have we reached a plateau in our CML Care?
Dr. H Malhotra, Jaipur
Somatic mutations in aplastic anaemia- Do they influence my practice?
Dr. Velu Nair, Delhi
Flowcytometric Approach to CLPD diagnosis
Dr. Prashant Tembhare, Mumbai
Role of Gut microbiome in Haematology
Dr.Vineet Ahuja, Delhi
15.20 – 15.40 Laboratory Monitoring of BCR-ABL: Challenges in India
Dr. P. Balasubramanian, Vellore
Hypo cellular Bone marrow:
Aplastic Anemia vs MDS
Dr. Shanaz Khodaiji, Mumbai
Evolution of CLL treatment from chemo-immunotherapy to individual therapy:
Dr. Joseph John, Ludhiana
Viral Infections in BMT : Beyond CMV and EBV
Dr. Harshit Khurana, Bengaluru
15.40 – 16.00 Treatment Free Remission for CML in India: Are we ready?
Dr. Soniya Nityanand, Lucknow
Sequencing treatment options in a young Aplastic Anemia Patient;
Dr. Biju George, Vellore
Driving CARs in Aggressive Lymphomas
Dr. Saurabh Dahiya, USA
Platelet refractoriness: Evaluation and management
Dr. Jina Bhattachrya, Guwahati
16.00 – 16.15 Discussion Discussion
16.15 – 16.45 TEA BREAK WITH POSTER WALK
16.45 – 17.30 DEBATE (Clinical)
[Chairs: Dr. Rajat Kumar, Canada; ]
DEBATE ( Laboratory)
[Chair: Dr. H.P.Pati, Delhi]
Learning Through interesting Case/s (Laboratory) Learning Through interesting Case (Clinical)
Post-transplant Cyclophosphamide is now the accepted standard of care for GVHD prophylaxis Flowcytometry is essential for Diagnosis of Myelodysplastic Syndrome Hemoglobinopathies: (20min): Dr. Reena Das, Chandigarh Eosinophilia ( 20 min):
Dr. Rahul Naithani, Delhi
16.45 – 17.00
17.00- 17.15
Yes: Dr. Minoo Battiwalla, USA
No: Dr. Tapan Saikia, Mumbai
Yes: Dr. AK Handoo, Delhi
No: Dr. P G Subramanian, Mumbai
T-cell Lymphomas ( 20 min):
Dr. S. Gujral, Mumbai
Refractory/Relapsed AML ( 20 min):
Dr. Arjun Datt Law, Canada
17.15 – 17.30 Discusssion Discussion
17.45 – 18.45 Sponsored Symposium
( INTAS)
Sponsored Symposium
( HORIBA)
Sponsored Symposium
( JANSSEN)
Sponsored Symposium
( ASTRAGENICA)
18.45 –19.00 BREAK
19.00 – 20.00 GENERAL BODY MEETING
20.00 Onwards BANQUET DINNER
CONFERENCE DAY 3 –10TH NOVEMBER 2019
TIME HALL A HALL B
08.00 – 09.30 NATIONAL HEMATOLOGY ISHBT QUIZ
09.30 – 11.00 JC PATEL AWARD SESSION
11.00 – 11.15 Break
11.15 – 12.30 Thrombocytopenia1 ALL1
11.15 – 11.35 Diagnosis of ITP: how much to investigate?
Dr. Rakhee Kar, Puducherry
Ph-Like ALL: When to suspect and How to diagnose?
Dr. Manju Sengar, Mumbai
11.35 – 11.55 Is splenectomy still an option for refractory ITP in 2019
Dr. Tuphan Dolai, Kolkata
Treatment dilemmas in MPAL: Myeloid vs. Lymphoid
Dr. Pawan Kumar Singh, Delhi
11.55 – 12.15 Trombocytopenia in Pregnancy: Management approach
Dr. Satyaranjan Das, Prayagraj
Incorporating Monoclonal Antibodies in ALL Treatment:
Dr. Ashish Dixit, Bengaluru
12.15 – 12.30 Discussion
12.30 – 13.30 Hematopathology2 Supportive Care 2
12.30 – 12.50 Laboratory Approach to Polycythemia
Dr. Ruchi Gupta; Lucknow
Fertility Preservation in Hematological malignancy: for whom and How?
Dr. Sanjeevan Sharma, Pune
12.50 – 13.10 MDS-MPN Disorders: Diagnostic Issues
Dr. Abhishek Purohit, Jodhpur
Breakthrough mold infections in hematology
Dr. Narendra Agrawal, Delhi
13.10 – 1.30 Diagnosis of Mastocytosis
Dr. Shano Naseem, Chandigarh
Nutritional support and mucositis care in BMT
Dr. Uday Yanmandra, Delhi
13.30 Onwards VALEDICTORY FUNCTION AND PRIZE DISTRIBUTION FOLLOWED BY LUNCH

NOTE: Subject to changes.

Conference Secretariat


Department of Haematology and
Haematology Education & Research Society,
New Private Ward, 2nd Floor,
All India Institute of Medical Sciences (AIIMS),
New Delhi – 110029
E: admin@haematocon.in